{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:54:44Z","timestamp":1767840884396,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1136\/ijgc-2020-001797","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T17:05:46Z","timestamp":1604077546000},"page":"78-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Neoadjuvant radiotherapy and brachytherapy in endometrial cancer with gross cervical involvement: a CHIRENDO research group study"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7595-0313","authenticated-orcid":false,"given":"Melica Nourmoussavi","family":"Brodeur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Samou\u00eblian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohann","family":"Dabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9atrice","family":"Cormier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Claude","family":"Beauchemin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maroie","family":"Barkati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2020-001797_bb0010","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2020-001797_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ijgo.12612","article-title":"Cancer of the corpus uteri","volume":"143 Suppl 2","author":"Amant","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2020-001797_bb0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ygyno.2017.08.021","article-title":"Outcomes of stage II endometrial cancer: the UPMC Hillman cancer center experience","volume":"147","author":"Chen","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001797_bb0025","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/IGC.0000000000001030","article-title":"Oncologic outcomes after adjuvant radiotherapy for stage II endometrial carcinoma: a Korean Radiation Oncology Group study (KROG 14-10)","volume":"27","author":"Jung","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001797_bb0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/igc.0000000000001133","article-title":"Oncological outcomes of stage II endometrial cancer: a retrospective analysis of 250 cases","volume":"28","author":"Ozgul","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001797_bb0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ygyno.2014.12.012","article-title":"Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution study","volume":"136","author":"Elshaikh","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001797_bb0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.brachy.2017.10.011","article-title":"The impact of adjuvant vaginal brachytherapy in women with stage II uterine endometrioid carcinoma: results of a national cancer database analysis","volume":"17","author":"Lee","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2020-001797_bb0045","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/bjc.2013.521","article-title":"Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?","volume":"109","author":"Takano","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2020-001797_bb0050","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ijrobp.2018.04.049","article-title":"Multi-Institutional analysis of vaginal brachytherapy alone for women with stage II endometrial carcinoma","volume":"101","author":"Harkenrider","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2020-001797_bb0055","doi-asserted-by":"crossref","first-page":"170","DOI":"10.6004\/jnccn.2018.0006","article-title":"Uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Koh","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1136\/ijgc-2020-001797_bb0060","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1006\/gyno.1993.1297","article-title":"Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement","volume":"51","author":"Boente","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001797_bb0065","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/ijgc-00009577-200111000-00002","article-title":"Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy","volume":"11","author":"Sartori","year":"2001","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001797_bb0070","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2018.29.e76","article-title":"Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: a Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study","volume":"29","author":"Fu","year":"2018","journal-title":"J Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001797_bb0075","first-page":"781","article-title":"Comparative analyses of postoperative complications and prognosis of different surgical procedures in stage II endometrial carcinoma treatment","volume":"9","author":"Yin","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1136\/ijgc-2020-001797_bb0080","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2020-001797_bb0085","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2020-001797_bb0090","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/gyno.1998.5148","article-title":"High-dose-rate brachytherapy for medically inoperable stage I endometrial cancer","volume":"71","author":"Nguyen","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001797_bb0095","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/1097-0142(19910915)68:6<1261::AID-CNCR2820680614>3.0.CO;2-V","article-title":"Preoperative radiation therapy followed by extrafascial hysterectomy in patients with stage II endometrial carcinoma","volume":"68","author":"Higgins","year":"1991","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2020-001797_bb0100","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0360-3016(98)00074-1","article-title":"Preoperative radiotherapy and surgery for endometrial carcinoma: prognostic significance of the sterilization of the specimen","volume":"41","author":"Maingon","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2020-001797_bb0105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5114\/jcb.2011.23200","article-title":"Preoperative high dose rate brachytherapy for clinical stage II endometrial carcinoma","volume":"3","author":"Shukla","year":"2011","journal-title":"J Contemp Brachytherapy"},{"key":"10.1136\/ijgc-2020-001797_bb0110","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1701-2163(15)30893-8","article-title":"Preoperative radiotherapy for inoperable stage II endometrial cancer: insights into improving treatment and outcomes","volume":"35","author":"Lee","year":"2013","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1136\/ijgc-2020-001797_bb0115","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2014.09.001","article-title":"Neoadjuvant radiotherapy with or without chemotherapy followed by extrafascial hysterectomy for locally advanced endometrial cancer clinically extending to the cervix or parametria","volume":"135","author":"Vargo","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001797_bb0120","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ijrobp.2016.12.035","article-title":"Brachytherapy improves survival in stage III endometrial cancer with cervical involvement","volume":"97","author":"Bingham","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2020-001797_bb0125","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1245\/s10434-016-5372-3","article-title":"Impact of radical hysterectomy on survival in patients with stage 2 type 1 endometrial carcinoma: a matched cohort study","volume":"23","author":"Phelippeau","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1136\/ijgc-2020-001797_bb0130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ygyno.2020.02.003","article-title":"Radical hysterectomy is not associated with a survival benefit for patients with stage II endometrial carcinoma","volume":"157","author":"Nasioudis","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001797_bb0135","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/01.AOG.0000260871.87607.25","article-title":"Clinical and pathologic correlates in surgical stage II endometrial carcinoma","volume":"109","author":"Cohn","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001797_bb0140","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1470-2045(19)30395-X","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial","volume":"20","author":"de Boer","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2020-001797_bb0145","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa1813181","article-title":"Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer","volume":"380","author":"Matei","year":"2019","journal-title":"N Engl J Med"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24026240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24026240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2020-001797","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:26:39Z","timestamp":1753233999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24026240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1048891X24026240"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2020-001797","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant radiotherapy and brachytherapy in endometrial cancer with gross cervical involvement: a CHIRENDO research group study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2020-001797","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}